Summer reflections on transforming health – a word from our director
IHI kicked off July with our thirteenth call –on tackling immune diseases in the elderly, building a network for health innovators and reducing animal testing. All materials from our call days are now online to help you build strong proposals. The deadline is 8 October.
The key to a strong proposal and a successful IHI project is to bring in all the stakeholders needed to transform innovation into long-lasting impact. The newly-published IHI In Focus – with highlights from 2025 - provides many examples and a deep-dive into our cancer projects.
Catching up with alumni of IMI projects, we spoke to Aurora Signorazzi, now a regulator at the Dutch medicines agency. She developed alternatives to animal testing for her PhD as part of the VAC-2-VAC project, and describes how the public-private partnership shaped her career by exposing her to regulatory affairs.
IHI strives for deep patient engagement. This often means training people living with disease to understand and participate in research. Our project GREG, with EUPATI, is now flipping the script: training researchers how to effectively involve patients in data-driven research - doing research differently and shaping questions to do different research.
IHI’s legacy will be such bold, collaborative partnerships that drive long-lasting, transformative impact. This is the theme of the IHI Forum, taking place in October. Join us for our flagship event on public-private partnerships that are revolutionising health – registration is now open!
Niklas Blomberg, IHI Executive Director
The key to a strong proposal and a successful IHI project is to bring in all the stakeholders needed to transform innovation into long-lasting impact. The newly-published IHI In Focus – with highlights from 2025 - provides many examples and a deep-dive into our cancer projects.
Catching up with alumni of IMI projects, we spoke to Aurora Signorazzi, now a regulator at the Dutch medicines agency. She developed alternatives to animal testing for her PhD as part of the VAC-2-VAC project, and describes how the public-private partnership shaped her career by exposing her to regulatory affairs.
IHI strives for deep patient engagement. This often means training people living with disease to understand and participate in research. Our project GREG, with EUPATI, is now flipping the script: training researchers how to effectively involve patients in data-driven research - doing research differently and shaping questions to do different research.
IHI’s legacy will be such bold, collaborative partnerships that drive long-lasting, transformative impact. This is the theme of the IHI Forum, taking place in October. Join us for our flagship event on public-private partnerships that are revolutionising health – registration is now open!
Niklas Blomberg, IHI Executive Director
IHI’s 13th call is now open!
This €84.8 million call will support health innovators, reduce animal use in drug safety studies and tackle diseases related to ageing and the immune system.
Registration now open for IHI Forum 2026!
Registration is now open for the IHI Forum 2026 and the agenda is online! The event will be held in Brussels and online on 20-21 October.
Sign up today.
Sign up today.
IHI In Focus now published - find out what we got up to in 2025!
What did IHI get up to in 2025? Read our brochure for the highlights!
Find out more
Developing animal-free methods with the VAC-2-VAC project
Aurora Signorazzi, a PhD student in the VAC-2-VAC project, forged a career in industry and pharmaceutical regulation. She told us how working in a PPP shaped her future.
Accelerating vaccine manufacturing using Inno4Vac’s CADET-Hub
The Inno4Vac project developed a computer-based tool to model key parts of biopharmaceutical workflows.
HEU-EFS delivers a harmonised framework to boost the use of early feasibility studies
Early feasibility studies can accelerate innovation in medical devices, and HEU-EFS developed a framework to outline how to implement or assess them in Europe.
How to meaningfully involve patients in an IHI project
The GREG project outlined a systematic plan for patient involvement, including training delivered by EUPATI and KPIs for follow-up.
COMPASS points way to better heart health in cancer care
Many cancer treatments come with cardiovascular disease as a side effect. New project COMPASS aims to tackle this head-on.
GUIDE-AI to help to chart course through treatment guidelines
The new project will develop AI-powered navigators to steer doctors through the maze of treatment guidelines and ensure patients receive the right treatment.
EXIT-CVD seeks exit routes from heart disease pathway
The new project aims to pinpoint exit points along the cardiovascular disease continuum plus test and treatments that will stop CVDs in their tracks.
PATH to pave the way for integrating AI into cancer care
Cancer patients generate a wealth of data; new project PATH wants to use it to develop AI tools to improve cancer care.
IMPACT-MED seeks to join the dots in cardiometabolic disease care
The new project will pave the way for more integrated, proactive, personalised care for cardiometabolic diseases like high blood pressure and diabetes.
Find out more